Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

1. Figuero-Pérez, L.
2. Olivares-Hernández, A.
3. Escala-Cornejo, R.A.
4. Terán-Brage, E.
5. López-Gutiérrez, Á.
6. Cruz-Hernández, J.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.REUMA.2020.06.003 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus